🇺🇸 FDA

Intelligence Platform

Patents

Browse 454 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7777034

Crystalline ammonium salts of rosuvastatin

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7772219

Methods of hormonal treatment utilizing extended cycle contraceptive regimens

TEVA WOMEN'S HEALTH, INC. · Granted Tue Aug 10 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7759500

2-(N-methyl-propanamine)-3-(2-naphthol)thiophene, an impurity of duloxetine hydrochloride

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jul 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7750051

Crystalline solid rasagiline base

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jul 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7749536

Pharmaceutical formulations of aliphatic amine polymers and methods for their manufacture

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jul 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7741482

Reference standard for characterization of rosuvastatin

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jun 22 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 17 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7737177

Processes for preparing crystalline and amorphous mupirocin calcium

TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság · Granted Tue Jun 15 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 10 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7692008

Reference standard for characterization of rosuvastatin

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Apr 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7692010

Reference standard for characterization of rosuvastatin

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Apr 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7692009

Reference standard for characterization of rosuvastatin

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Apr 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7687642

Fluvastatin sodium crystal forms, processes for preparing them, compositions containing th

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7687622

Process for preparing quetiapine fumarate

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7687660

Process for preparing intermediates of HMG-CoA reductase inhibitors

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7683080

Stable iansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more tha

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7683188

Process for preparation of mycophenolic acid and ester derivatives thereof

TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság · Granted Tue Mar 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7683177

Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel c

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7678938

Optical resolution of 3-carbamoylmethyl-5-methyl hexanoic acid

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7678816

Method of stabilizing lansoprazole

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7678799

Crystalline ziprasidone HCl and processes for preparation thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7674935

Crystal forms of O-desmethylvenlafaxine

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7674923

Process for preparing forms of atorvastatin calcium substantially free of impurities

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7674480

Rapidly expanding composition for gastric retention and controlled release of therapeutic

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7671071

Polymorphic Form XVI of fexofenadine hydrochloride

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7645876

Processes for producing crystalline macrolides

TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság · Granted Tue Jan 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted